CommercialCoverageLow impact
Medical Policy Update
Blue Cross Blue Shield of Kansas·KS · Hematology, Oncology·Medical Policy
Effective date
Apr 5, 2023
We identified it
Jun 19, 2026
Summary
Blue Cross Blue Shield of Kansas has published an updated medical policy for Hemophilia B Gene Therapy Medical Drug Criteria Program. This is an informational notification about the policy update being available on their website.
Action Required
Review the updated Hemophilia B Gene Therapy Medical Drug Criteria policy on the BCBSKS website to understand any changes to coverage criteria or documentation requirements. Contact BCBSKS provider consultant if questions arise about the updated policy.